Dr. Hugo E.M. Vereecke

Dr. Hugo E.M. Vereecke (°04/07/1972) became a medical doctor at the Ghent University, Belgium (1997) and consultant anesthesiologist (2002) at the University Hospital Ghent, Belgium.
After finalizing his PhD Thesis (2007) on improving anesthetic drug titration using neuro-physiological monitoring, he proceeded an academic career at the University Medical Center Groningen (UMCG) (2010-current), the Netherlands, where he became an assistant professor in anesthesia (2012-current).
He is involved in multiple study-projects related to anesthetic pharmacology, such as: the improvement of pharmacokinetic-dynamic models for anesthetic drugs; using interaction models to predict responsiveness during anesthesia; exploring the use of electroencephalographic derived information to individualize titration of anesthetic drugs.
Dr. Hugo E.M. Vereecke currently combines his academic position with a clinical consultancy at the general hospital AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium (2016-current). He is an experienced lecturer and educator in his domain of expertise. He is co-promotor of several PhD’s and masterthesis. He volunteered in several professional societies and committees: the medical ethical
committee (2014-2016), the sedation committee (2012-2016) and chair of the incident notification commission (2012-2016) at the UMCG, program director, co chair and chair of the scientific programs of several annual meetings of ISAP (San Diego (2015) , Chicago (2017), New Orleans (2022) and the virtual meetings during the COVID pandemic in 2020 and 2021. He is the former treasurer
(2017-2018), secretarial officer (2018-2019), vice-president (2019-2020), president-elect (2020- 2021), and president (2021-2022) of the International
Society of Anaesthetic Pharmacology (ISAP). He was active member of forum 1 of the European Society of Anesthesia and Intensive care (ESAIC) (2018-2023). He is a board member of EuroSIVA(2023-current). His publication list includes peer reviewed research papers, book chapters and
editorials in several national and international scientific journals.

Share the Post:

Related Posts

EuroSIVA in Abu Dhabi: A Successful First Step ✨

On 14 September 2025, EuroSIVA had the privilege of participating in the Abu Dhabi Annual Anesthesia Congress (ADAAC), organized in conjunction with the Euro-Abu Dhabi Intensive Care Congress. For the first time in the Middle East, we hosted a TIVA/TCI Workshop at the Conrad Abu Dhabi Etihad Towers. The program included lectures on pharmacokinetics, pharmacodynamics, EEG monitoring, and drug interactions, as well as sessions on PK/PD modeling, TCI in special populations (children, elderly, obese), and practical exercises with TCI pumps

Read More

EUROSIVA 2025: A Historic Milestone in Buenos Aires

Following previous scientific events in Chile (2011 and 2019) and Colombia (2013), EUROSIVA once again crossed European borders — this time to Buenos Aires, which proved to be the ideal host. From May 15th to 17th, over 550 anesthesia professionals, including 70 colleagues from Latin America, gathered for a unique, immersive event centered on Total Intravenous Anesthesia (TIVA) and intraoperative monitoring. This remarkable edition of EUROSIVA was made possible through the invaluable collaboration with FAAAAR (Argentinian Federation of Anesthesia, Analgesia

Read More

Join Our Newsletter

Please enable JavaScript in your browser to complete this form.
Scroll al inicio

This website collects cookies to deliver better user experience